Having demonstrated that gene mutations in MM cell lines are linked to drug sensitivities towards PI3K and MEK inhibitors, we were then interested in studying how expression levels of the pathway (phospho) proteins correlated with their drug sensitivity. Here, PIK3CA is linked to Miyoshi myopathy.